Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Davidson KW, Barry MJ, Mangione CM, et al. JAMA. 2022;327:1577-84. 35471505.

Download full-text PDF

Source
http://dx.doi.org/10.7326/J22-0064DOI Listing

Publication Analysis

Top Keywords

uspstf recommends
4
recommends aspirin
4
aspirin prevent
4
prevent cvd
4
cvd adults
4
adults individual
4
individual decision
4
decision recommended
4
recommended adults
4
adults ≥60
4

Similar Publications

Importance: Black individuals have a twofold higher rate of prostate cancer death in the US compared with the average population with prostate cancer. Few guidelines support race-conscious screening practices among at-risk Black individuals.

Objective: To examine structural factors that facilitate or impede access to prostate cancer screening among Black individuals in the US.

View Article and Find Full Text PDF

Background: The United States Preventive Services Task Force (USPSTF) provides age-based recommendations for prostate cancer screening. Such a single-criterion strategy can not only miss aggressive cancers that occur before the designated cut-off age, but also over-screen men whose cancers occur at a much older age. A multi-factorial model incorporating a wide spectrum of medical history may offer more accurate predictions.

View Article and Find Full Text PDF

Preterm birth trends in the United States post aspirin recommendation guidelines.

J Natl Med Assoc

August 2025

Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.

Objectives: To evaluate changes in preterm birth (PTB) rates in the U.S. following the United States Preventive Services Task Force (USPSTF) aspirin recommendation guidelines.

View Article and Find Full Text PDF

Population screening is an effective strategy for disease prevention, early diagnosis and treatment; however, the benefits and harms of disease screening need to be carefully evaluated before clinical implementation. Various national and international bodies, including the U.S.

View Article and Find Full Text PDF